carbidopa and Parkinson Disease, Secondary

carbidopa has been researched along with Parkinson Disease, Secondary in 87 studies

Research

Studies (87)

Timeframe	Studies, this research(%)	All Research%
pre-1990	24 (27.59)	18.7374
1990's	44 (50.57)	18.2507
2000's	9 (10.34)	29.6817
2010's	7 (8.05)	24.3611
2020's	3 (3.45)	2.80

Authors

Authors	Studies
Guerrero, MF; López, JL; Olaya, MDP; Vergel, NE; Viña, MD	1
Balogun, CI; Fatoki, AM; Oladimeji, S; Olofinnade, AT; Onaolapo, AY; Onaolapo, OJ; Onaolapo, TM	1
Bolia, R; Panda, PK; Sharawat, IK; Shrivastava, Y	1
Azandeh, SS; Farbood, Y; Ghasemi Dehcheshmeh, M; Jalali, MS; Mansouri, E; Saki, G; Sarkaki, A	1
Hattori, T; Karasawa, H; Mogami, S; Taché, Y; Wang, L; Yakabi, K; Yakabi, S; Yamada, C	1
Chang, MC; Chun, MH; Kang, CG; Kong, EJ	1
Harada, N; Kakiuchi, T; Kanazawa, M; Muramatsu, S; Ohba, H; Tsukada, H	1
Brauer, AF; Ciucci, MR; Kelm-Nelson, CA	1
Frei, K; Truong, DD; Wolters, E	1
Arami, MA; Ayromlou, H; Najmi, S	1
Ahmad, M; Gupta, A; Rizvi, I; Zaidi, N	1
Borra, S; Hauser, RA; Zesiewicz, TA	1
Bojko, A; Chutorian, AM; Edelberg, D; Frucht, S; Heier, L; Nygaard, T	1
Delville, Y; Fleming, SM; Schallert, T	1
Eskey, CJ; Gardner, TB; Lewis, LD; Nierenberg, DW; Osterling, W; Reddy, NJ	1
Shoulson, I	1
Bitton, V; Melamed, E	1
Ballard, P; Langston, JW	1
Kamenetskiĭ, VK	1
Ayalon, D; Rabey, JM; Ravid, R; Vardi, Y	1
Fahn, S	1
Lang, AE	1
Lunn, V; Northcott, C; Yatham, LN	1
D'Costa, DF; Moore-Smith, B; Phillips, PA; Sheehan, LJ	1
Fukuuchi, Y; Kobari, M; Nogawa, S; Obara, K; Shinohara, T	1
Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ	1
Carmichael, SW; Cook, JA; Merkel, GJ; Stoddard, SL; Zinsmeister, AR	1
Chutorian, AM; Levine, RA; Naini, AB; Nygaard, TG; Waran, SP	1
Ball, MC; Sagar, HJ	1
Caligiuri, MP	1
Bankiewicz, KS; de Jesus, S; Sheng, J; Takubo, H; Thomas, J; Wang, J	1
Bédard, PJ; Blanchette, P; DiPaolo, T; Falardeau, P; Gagnon, C; Gomez-Mancilla, B	1
Eller, RV; Gash, DM; Greenamyre, JT; Kurlan, R; Ovadia, A; Zhang, Z	1
Amantea, MA; Bravi, D; Chase, TN; Cora-Locatelli, G; Mouradian, MM; Roberts, JW	1
Ahlskog, JE; Atkinson, EJ; Cha, RH; Maraganore, DM; Muenter, MD; O'Brien, PC; Uitti, RJ	1
Imai, H; Kondo, T; Nakamura, T; Narabayashi, H	1
Gash, DM; Kurlan, R; McDermott, M; Smith, RD; Zhang, Z	1
Goldhammer, Y; Sadeh, M	1
Kulkantrakorn, K; Petruska, PJ; Selhorst, JB	1
Beal, MF; Calne, DB; Good, PF; Hewitt, KA; Olanow, CW; Perl, DP; Shinotoh, H; Snow, BJ; Vingerhoets, F	1
Arnold, G; Eichhorn, TE; Gasser, T; Mai, N; Marquardt, C; Oertel, WH; Schwarz, J	1
Jackson, M; Jenner, P; Marsden, CD; Pearce, RK; Smith, L	1
Andersen, AH; Avison, MJ; Chen, Q; Gash, DM; Ovadia, A; Zhang, Z	1
Ashworth, S; Bloomfield, PM; Fricker, RA; Hume, SP; Jones, T; Lammertsma, AA; Myers, R; Rajeswaran, S; Torres, EM; Watson, I	1
Moses, J; Siddiqui, A; Silverman, PB	1
Aoki, K; Ikeda, K; Kinoshita, M; Tomatsuri, A	1
Emerich, DF; Francis, JM; Lindner, MD; Plone, MA	1
Blaney, TJ; Chandonait, SE; Emerich, DF; Lindner, MD; Mullins, TD; Plone, MA; Sherman, SS; Stott, JA; Winn, SR	1
Andrén, PE; Ekesbo, A; Gunne, LM; Tedroff, J	1
Collins, F; Gash, DM; Hilt, D; Kryscio, R; Lapchak, PA; Lebel, C; Miyoshi, Y; Ovadia, A; Zhang, Z	1
Aggarwal, S; Childers, MK; Jimenez, D	1
Golubev, VL; Shtul'man, DR; Shvareva, IS; Veĭn, AM; Zhuchenko, TD	1
Lapchak, PA	1
Onofrj, M; Paci, C; Thomas, A	1
Adair, JC; Davis, LE	1
Andersen, AH; Avison, MJ; Gash, DM	1
Ahlskog, JE	1
Mandel, RJ	1
Jackson, MJ; Jenner, P; Kanda, T; Kase, H; Kuwana, Y; Nakamura, J; Pearce, RK; Smith, LA	1
Bankiewicz, KS; Bringas, J; Budinger, TF; Cunningham, J; Eberling, JL; Harvey-White, J; Jagust, W; Kohutnicka, M; Pivirotto, P	1
Kaku, DA; Sarasombath, P; Sumida, K	1
Battista, AF; Goldstein, M; Lew, JY; Lieberman, A; Matsumoto, Y	1
Finn, BW; Mendez, JS	1
Caine, ED; Davis, GC; Ebert, MH; Kopin, IJ; Markey, SP; Reichert, CM; Williams, AC	1
Del Pesce, M; Di Bella, P; Forastieri, L; Paggi, A; Quattrini, A	1
Albizzati, MG; Frattola, L; Scarlato, G; Trabucchi, M	1
Agnoli, A; Denaro, A; Lelli, A; Ruggieri, S	1
Carolei, A; Casacchi, M; Fazio, C	1
Marsden, CD; Parkes, JD; Tarsy, D	1
Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA	1
Camarata, PJ; Chae, H; Ebner, TJ; Haines, SJ; Park, SK; Parker, RG; Turner, DA	1
Balottin, U; Borgatti, R; Lanzi, G; Zambrino, CA	1
Ashwood, TJ; Bateman, DN; Tulloch, JA; Woodhouse, KW	1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ; Tye, S	1
Gash, DM; Kim, MH; Kurlan, R	1
Bodis-Wollner, I; Chung, E; Ghilardi, MF; Glover, A; Onofrj, M; Pasik, P; Samson, Y	1
Boyce, S; Clarke, CA; Crossman, AR; Robertson, RG; Sambrook, MA	1
Critchley, P; Grandas, F; Marsden, CD; Quinn, N; Rohan, A; Stahl, SM	1
Jankovic, J	1
Bioulac, B; Doudet, D; Gross, C; Lebrun-Grandié, P	2
Brown, RG; Gotham, AM; Marsden, CD; Nissenbaum, H; Quinn, NP; Toone, B	1
Lieberman, AN	1
Bankiewicz, KS; Chiueh, CC; Doppman, JL; Jacobowitz, DM; Kopin, IJ; Oldfield, EH	1
Duvoisin, RC; Sage, JI	1
Luque, FA; Petruska, P; Selhorst, JB	1
Chase, TN	1

Reviews

5 review(s) available for carbidopa and Parkinson Disease, Secondary

Article	Year
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4 Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed	1995
A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13 Suppl 1 Topics: Animals; Antiparkinson Agents; Carbidopa; Corpus Striatum; Dopamine; Drug Combinations; Drug Evaluation, Preclinical; Drug Therapy, Combination; Glial Cell Line-Derived Neurotrophic Factor; Humans; Levodopa; Nerve Growth Factors; Nerve Regeneration; Nerve Tissue Proteins; Neuroglia; Neuronal Plasticity; Parkinson Disease, Secondary; Substantia Nigra; Tyrosine 3-Monooxygenase	1998
Medical treatment of later-stage motor problems of Parkinson disease. Mayo Clinic proceedings, 1999, Volume: 74, Issue:12 Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cholinergic Antagonists; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitriles; Nitrophenols; Parkinson Disease, Secondary; Propranolol; Randomized Controlled Trials as Topic; Selegiline; Tolcapone	1999
Parkinson's disease: recent advances in therapy. Southern medical journal, 1988, Volume: 81, Issue:8 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Antiparkinson Agents; Carbidopa; Dopamine; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pyridines	1988
Serotonergic mechanisms and extrapyramidal function in man. Advances in neurology, 1974, Volume: 5 Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extrapyramidal Tracts; Fenclonine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Imipramine; Levodopa; Muscular Diseases; Paralysis; Parkinson Disease; Parkinson Disease, Secondary; Probenecid; Reserpine; Serotonin; Spinal Cord Diseases; Tetrabenazine; Time Factors	1974

Trials

5 trial(s) available for carbidopa and Parkinson Disease, Secondary

Article	Year
Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients. Neurology, 1993, Volume: 43, Issue:12 Topics: Adolescent; Adult; Aged; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Drug Synergism; Humans; Levodopa; Middle Aged; Nitrophenols; Parkinson Disease, Secondary; Placebos; Tolcapone	1993
Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome. Acta endocrinologica. Supplementum, 1978, Volume: 216 Topics: Animals; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease, Secondary; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine	1978
[Efficacy and side-effects of long term L-dopa therapy in Parkinsonian syndromes (evaluated by CT scan as well) (author's transl)]. Rivista di patologia nervosa e mentale, 1979, Volume: 99, Issue:5 Topics: Adult; Benserazide; Brain; Carbidopa; Clinical Trials as Topic; Confusion; Electrocardiography; Electroencephalography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Stomach Diseases; Tomography, X-Ray Computed	1979
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias. Journal of neurology, neurosurgery, and psychiatry, 1975, Volume: 38, Issue:4 Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine	1975
A single-dose study of the pharmacodynamic effects of chlormethiazole, temazepam and placebo in elderly parkinsonian patients. Age and ageing, 1991, Volume: 20, Issue:6 Topics: Aged; Benserazide; Carbidopa; Chlormethiazole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Sleep Initiation and Maintenance Disorders; Sleep Stages; Temazepam	1991

Other Studies

77 other study(ies) available for carbidopa and Parkinson Disease, Secondary

Article	Year
Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent Biomedica : revista del Instituto Nacional de Salud, 2019, 09-01, Volume: 39, Issue:3 Topics: Animals; Antiparkinson Agents; Carbidopa; Catalepsy; Coumarins; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Locomotion; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Reserpine	2019
An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice. Central nervous system agents in medicinal chemistry, 2020, Volume: 20, Issue:1 Topics: Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Behavior, Animal; Body Weight; Carbidopa; Chlorpromazine; Diet; Drug Combinations; Eating; Grooming; Levodopa; Lipid Peroxidation; Mice; Motor Activity; Parkinson Disease, Secondary; Pyridoxal Phosphate	2020
Case Report: Dengue Virus-Triggered Parkinsonism in an Adolescent. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:2 Topics: Adolescent; Antiparkinson Agents; Brain; Carbidopa; Dengue; Diffusion Magnetic Resonance Imaging; Drug Combinations; Electroencephalography; Humans; India; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease, Secondary; Treatment Outcome	2020
Therapeutic effects of Wharton's jelly-derived Mesenchymal Stromal Cells on behaviors, EEG changes and NGF-1 in rat model of the Parkinson's disease. Journal of chemical neuroanatomy, 2021, Volume: 113 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Dopaminergic Neurons; Drug Combinations; Electroencephalography; Insulin-Like Growth Factor I; Levodopa; Male; Medial Forebrain Bundle; Mesenchymal Stem Cell Transplantation; Motor Activity; Nerve Growth Factor; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Substantia Nigra; Wharton Jelly	2021
Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats. Peptides, 2014, Volume: 55 Topics: Animals; Carbidopa; Drugs, Chinese Herbal; Gastric Emptying; Ghrelin; Levodopa; Male; Oligopeptides; Parkinson Disease, Secondary; Postprandial Period; Rats, Sprague-Dawley; Receptors, Ghrelin	2014
Parkinsonism after external ventricular drainage in a patient with intraventricular hemorrhage. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2015, Volume: 24, Issue:3 Topics: Activities of Daily Living; Carbidopa; Caudate Nucleus; Cerebral Ventricles; Drainage; Drug Combinations; Female; Humans; Intracranial Hemorrhages; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease, Secondary; Positron-Emission Tomography; Predictive Value of Tests; Putamen; Radiopharmaceuticals; Recovery of Function; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tropanes; Ventriculoperitoneal Shunt	2015
Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2 Topics: Animals; Brain; Carbidopa; Dihydroxyphenylalanine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Presynaptic; Tyrosine	2016
Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease. Behavioural brain research, 2016, 07-01, Volume: 307 Topics: Animals; Antiparkinson Agents; Apomorphine; Carbidopa; Communication Disorders; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Combinations; Fourier Analysis; Levodopa; Male; Neurotoxins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Long-Evans; Stereotyped Behavior; Time Factors; Ultrasonics; Vocalization, Animal	2016
Case studies in the advancement of Parkinson's disease. CNS spectrums, 2008, Volume: 13, Issue:12 Suppl 1 Topics: Aged; Antiparkinson Agents; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary	2008
Hemiparkinsonism-hemiatrophy syndrome. Archives of Iranian medicine, 2011, Volume: 14, Issue:2 Topics: Adult; Antiparkinson Agents; Atrophy; Benzothiazoles; Biperiden; Carbidopa; Cerebral Cortex; Cerebral Ventricles; Dopamine Agonists; Drug Combinations; Humans; Indans; Levodopa; Magnetic Resonance Imaging; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Pramipexole; Tomography, X-Ray Computed	2011
Isolated extra pontine myelinolysis presenting as acute onset parkinsonism. BMJ case reports, 2012, Oct-12, Volume: 2012 Topics: Acute Disease; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Hyponatremia; Levodopa; Magnetic Resonance Imaging; Middle Aged; Myelinolysis, Central Pontine; Parkinson Disease, Secondary; Saline Solution, Hypertonic	2012
Clozapine withdrawal symptoms in a Parkinson's disease patient. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Aged; Antipsychotic Agents; Carbidopa; Clozapine; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Substance Withdrawal Syndrome	2002
Toxic pediatric parkinsonism: report of a child with metabolic studies and response to treatment. Journal of child neurology, 2003, Volume: 18, Issue:11 Topics: Antimetabolites, Antineoplastic; Antiparkinson Agents; Carbidopa; Child; Cytarabine; Humans; Levodopa; Male; Parkinson Disease, Secondary	2003
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. Behavioural brain research, 2005, Jan-30, Volume: 156, Issue:2 Topics: Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cell Count; Differential Threshold; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Immunohistochemistry; Levodopa; Male; Methylphenidate; Motor Activity; Movement; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Long-Evans; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase	2005
Two cases of rapid onset Parkinson's syndrome following toxic ingestion of ethylene glycol and methanol. Clinical pharmacology and therapeutics, 2007, Volume: 81, Issue:1 Topics: Acute Disease; Adult; Aged; Antiparkinson Agents; Basal Ganglia; Carbidopa; Ethylene Glycol; Female; Humans; Levodopa; Male; Methanol; Necrosis; Parkinson Disease, Secondary; Respiratory Insufficiency; Tomography, X-Ray Computed	2007
Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia. Advances in neurology, 1983, Volume: 37 Topics: Aged; Antipsychotic Agents; Carbidopa; Drug Combinations; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Outcome and Process Assessment, Health Care; Parkinson Disease; Parkinson Disease, Secondary	1983
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. The Journal of clinical psychiatry, 1984, Volume: 45, Issue:1 Topics: Aged; Antipsychotic Agents; Carbidopa; Corpus Striatum; Depressive Disorder; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Metoclopramide; Parkinson Disease, Secondary; Receptors, Dopamine	1984
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Carbidopa; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Pyridines	1984
[Treatment of patients with vascular parkinsonism with the preparations nakom and madopar]. Klinicheskaia meditsina, 1984, Volume: 62, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease, Secondary	1984
Dissociation of thyrotropin and prolactin responsiveness to thyrotropin releasing hormone stimulation in L-dopa treated parkinsonian patients. Hormone research, 1981, Volume: 15, Issue:2 Topics: Aged; Carbidopa; Drug Therapy, Combination; Humans; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone	1981
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents. Advances in neurology, 1983, Volume: 37 Topics: Adult; Aged; alpha-Methyltyrosine; Carbidopa; Dopamine; Dopamine Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reserpine; Synapses; Tetrabenazine	1983
Parkinsonism and bipolar affective disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:3 Topics: Aged; Antiparkinson Agents; Bipolar Disorder; Carbidopa; Clonazepam; Dopamine; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Lithium Carbonate; Male; Parkinson Disease, Secondary	1995
The levodopa test in Parkinson's disease. Age and ageing, 1995, Volume: 24, Issue:3 Topics: Aged; Aged, 80 and over; Carbidopa; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Geriatric Assessment; Humans; Levodopa; Male; Motor Skills; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Reaction Time; Walking	1995
Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders. Journal of the neurological sciences, 1995, Volume: 128, Issue:2 Topics: Adult; Aged; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed; Treatment Outcome; Xenon	1995
MRI and PET studies of manganese-intoxicated monkeys. Neurology, 1995, Volume: 45, Issue:6 Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed	1995
Adrenal medulla and Parkinson's disease. Microscopy research and technique, 1994, Oct-01, Volume: 29, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Animals; Carbidopa; Catecholamines; Disease Models, Animal; Drug Combinations; Humans; Levodopa; Male; Mice; Mice, Inbred C57BL; Parkinson Disease, Secondary	1994
Dopa-responsive dystonia simulating cerebral palsy. Pediatric neurology, 1994, Volume: 11, Issue:3 Topics: Adolescent; Adult; Biopterins; Carbidopa; Cerebral Palsy; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Female; Follow-Up Studies; Homovanillic Acid; Humans; Levodopa; Male; Neopterin; Neurologic Examination; Parkinson Disease, Secondary	1994
Levodopa in pregnancy. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:1 Topics: Adult; Carbidopa; Female; Humans; Levodopa; Lymphoma, Non-Hodgkin; Parkinson Disease, Secondary; Pregnancy; Pregnancy Complications; Pregnancy Outcome	1995
Portable device for quantifying parkinsonian wrist rigidity. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Antipsychotic Agents; Carbidopa; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Muscle Tonus; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Psychotic Disorders; Risk Factors; Transducers	1994
A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization. Experimental neurology, 1994, Volume: 126, Issue:2 Topics: Amphetamine; Animals; Brain; Carbidopa; Caudate Nucleus; Corpus Striatum; Dopamine; Drug Combinations; Functional Laterality; Immunohistochemistry; Levodopa; Male; Mesencephalon; Models, Neurological; Motor Activity; Nucleus Accumbens; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotation; Tyrosine 3-Monooxygenase	1994
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys. Advances in neurology, 1993, Volume: 60 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain Mapping; Carbidopa; Corpus Striatum; Dopamine Agents; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Dyskinesia, Drug-Induced; Female; Levodopa; Locomotion; Macaca fascicularis; Parkinson Disease, Secondary; Psychomotor Performance; Receptors, Dopamine D1; Receptors, Dopamine D2	1993
Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Annals of neurology, 1994, Volume: 35, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetamides; Analysis of Variance; Animals; Anticonvulsants; Antiparkinson Agents; Brain; Carbidopa; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Levodopa; Macaca mulatta; Male; Motor Activity; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reserpine; Time Factors	1994
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology, 1993, Volume: 43, Issue:10 Topics: Carbidopa; Female; Follow-Up Studies; Humans; Levodopa; Male; Minnesota; Parkinson Disease; Parkinson Disease, Secondary; Survival Analysis; Survival Rate; Time Factors	1993
Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP? Advances in neurology, 1993, Volume: 60 Topics: Benserazide; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Movement Disorders; Neurologic Examination; Ocular Motility Disorders; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive	1993
Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience, 1993, Volume: 52, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Feeding Behavior; Female; Injections, Intra-Arterial; Levodopa; Macaca mulatta; Motor Activity; Parkinson Disease, Secondary	1993
Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. European neurology, 1993, Volume: 33, Issue:1 Topics: Basal Ganglia Diseases; Biperiden; Carbidopa; Chlorthalidone; Coma; Drug Therapy, Combination; Female; Humans; Hypertension; Hyponatremia; Levodopa; Lisuride; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Pons; Quadriplegia; Saline Solution, Hypertonic; Tomography, X-Ray Computed	1993
Cytosine arabinoside and amphotericin B-induced parkinsonism. Annals of neurology, 1996, Volume: 39, Issue:3 Topics: Amphotericin B; Carbidopa; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelomonocytic, Acute; Levodopa; Lung Diseases; Middle Aged; Parkinson Disease, Secondary	1996
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology, 1996, Volume: 46, Issue:2 Topics: Animals; Basal Ganglia; Brain; Carbidopa; Chlorides; Gliosis; Globus Pallidus; Levodopa; Macaca mulatta; Male; Manganese Compounds; Manganese Poisoning; Parkinson Disease, Secondary; Poisoning; Substantia Nigra	1996
Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Brain; Carbidopa; Drug Therapy, Combination; Female; Handwriting; Humans; Levodopa; Male; Microcomputers; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Signal Processing, Computer-Assisted; Treatment Outcome	1996
Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus). Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Antiparkinson Agents; Callithrix; Carbidopa; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Neurologic Examination; Parkinson Disease, Secondary	1995
Mapping drug-induced changes in cerebral R2* by Multiple Gradient Recalled Echo functional MRI. Magnetic resonance imaging, 1996, Volume: 14, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Mapping; Carbidopa; Female; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Parkinson Disease, Secondary	1996
The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. Journal of neuroscience methods, 1996, Volume: 67, Issue:2 Topics: Animals; Carbidopa; Carbon Isotopes; Carrier Proteins; Cerebellum; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Huntington Disease; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tomography, Emission-Computed	1996
Sodium benzoate differentially blocks circling induced by D-and L-dopa in the hemi-parkinsonian rat. Neuroscience letters, 1996, Nov-08, Volume: 218, Issue:3 Topics: Amino Acid Oxidoreductases; Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Benzoates; Benzoic Acid; Carbidopa; Female; Food Preservatives; Levodopa; Locomotion; Parkinson Disease, Secondary; Phenylpyruvic Acids; Rats; Rats, Sprague-Dawley	1996
Hydrocephalic parkinsonism due to Paget's disease of bone: dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:2 Topics: Aged; Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Hydrocephalus; Levodopa; Neurologic Examination; Osteitis Deformans; Parkinson Disease, Secondary; Ventriculoperitoneal Shunt	1997
Validation of a rodent model of Parkinson's Disease: evidence of a therapeutic window for oral Sinemet. Brain research bulletin, 1996, Volume: 39, Issue:6 Topics: Administration, Oral; Animals; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Levodopa; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Stereotyped Behavior	1996
Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats. Experimental neurology, 1997, Volume: 145, Issue:1 Topics: Administration, Oral; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carbidopa; Cell Transplantation; Disease Models, Animal; Dopamine; Drug Combinations; Drug Synergism; Levodopa; Male; Movement Disorders; Neostriatum; Parkinson Disease, Secondary; PC12 Cells; Rats; Rats, Sprague-Dawley; Rotation	1997
(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease. Neuroreport, 1997, Jul-28, Volume: 8, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Carbidopa; Dopamine Antagonists; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Piperidines; Posture; Raclopride; Salicylamides	1997
Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys. Annals of neurology, 1997, Volume: 42, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Carbidopa; Cerebral Ventricles; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Female; Glial Cell Line-Derived Neurotrophic Factor; Injections, Intraventricular; Levodopa; Macaca mulatta; Motor Activity; Nerve Growth Factors; Nerve Tissue Proteins; Neuroprotective Agents; Parkinson Disease, Secondary; Stereotyped Behavior	1997
Use of carbidopa-levodopa in a patient with hydrocephalus and frozen movement. Brain injury, 1997, Volume: 11, Issue:11 Topics: Adult; Antiparkinson Agents; Basal Ganglia; Carbidopa; Cerebral Ventricles; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; Male; Parkinson Disease, Secondary; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventriculoperitoneal Shunt	1997
[Vascular parkinsonism]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1998, Volume: 98, Issue:4 Topics: Antiparkinson Agents; Brain Ischemia; Carbidopa; Drug Combinations; Electroencephalography; Female; Follow-Up Studies; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease, Secondary; Ultrasonography, Doppler, Transcranial	1998
Reversible parkinsonism induced by prolonged treatment with valproate. Journal of neurology, 1998, Volume: 245, Issue:12 Topics: Aged; Anticonvulsants; Antiparkinson Agents; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Remission Induction; Seizures; Valproic Acid	1998
Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3 Topics: Adult; Antiparkinson Agents; Brain Edema; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methanol; Parkinson Disease, Secondary; Putamen; Tomography, X-Ray Computed	1999
Principal component analysis of the dynamic response measured by fMRI: a generalized linear systems framework. Magnetic resonance imaging, 1999, Volume: 17, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Mapping; Carbidopa; Dopamine Agents; Female; Levodopa; Linear Models; Macaca mulatta; Magnetic Resonance Imaging; Mathematics; Models, Statistical; Parkinson Disease, Secondary; Regression Analysis; Systems Analysis	1999
Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease. Experimental neurology, 2000, Volume: 161, Issue:1 Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Male; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred F344; Rotation; Substantia Nigra; Sympatholytics	2000
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Experimental neurology, 2000, Volume: 162, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Callithrix; Carbidopa; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Injections, Intraperitoneal; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Purinergic P1 Receptor Antagonists; Purines; Quinpirole; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2	2000
Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Experimental neurology, 2000, Volume: 164, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Carbidopa; Catheterization; Caudate Nucleus; Cell Line; Dependovirus; Dopamine; Drug Administration Routes; Drug Combinations; Fluorine Radioisotopes; Genetic Therapy; Genetic Vectors; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Neurons; Parkinson Disease, Secondary; Prodrugs; Putamen; Tomography, Emission-Computed; Tyrosine; Tyrosine 3-Monooxygenase	2000
Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia. Hawaii medical journal, 2002, Volume: 61, Issue:3 Topics: Aged; Antineoplastic Agents; Antiparkinson Agents; Carbidopa; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Levodopa; Male; Parkinson Disease, Secondary; Recombinant Proteins; Treatment Outcome	2002
Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats. Journal of neurosurgery, 1975, Volume: 42, Issue:2 Topics: Animals; Apomorphine; Brain; Brain Chemistry; Carbidopa; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Levodopa; Male; Movement; Nerve Degeneration; Neurons; Neurotransmitter Agents; Oxotremorine; Parkinson Disease, Secondary; Rats; Rotation; Stereotaxic Techniques; Substantia Nigra; Synaptic Transmission; Time Factors	1975
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry research, 1979, Volume: 1, Issue:3 Topics: Adult; Bromocriptine; Carbidopa; Chronic Disease; Humans; Levodopa; Locus Coeruleus; Male; Meperidine; Opioid-Related Disorders; Parkinson Disease, Secondary; Substantia Nigra	1979
Hemiparkinsonism. A human model for studying dopaminergic supersensitivity. Archives of neurology, 1979, Volume: 36, Issue:4 Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Dextroamphetamine; Disease Models, Animal; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease, Secondary; Receptors, Dopamine	1979
Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study. Acta neurologica, 1978, Volume: 33, Issue:5 Topics: Administration, Oral; Adult; Aged; Carbidopa; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease, Secondary; Tremor; Trihexyphenidyl	1978
[Variations of the therapeutic action (on-off phenomenon) in patients with Parkin]. La Clinica terapeutica, 1977, Jan-31, Volume: 80, Issue:2 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Humans; Levodopa; Parkinson Disease, Secondary	1977
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates. Psychiatry research, 1992, Volume: 45, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed	1992
Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced hemiparkinsonism on the kinematics of a two-dimensional,multijoint arm movement in the rhesus monkey. Neuroscience, 1992, Volume: 48, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Arm; Behavior, Animal; Carbidopa; Female; Levodopa; Macaca mulatta; Male; Movement; Parkinson Disease, Secondary; Reaction Time; Substantia Nigra; Tyrosine 3-Monooxygenase	1992
Consideration on two cases of dystonia-parkinsonism. Italian journal of neurological sciences, 1991, Volume: 12, Issue:5 Topics: Carbidopa; Child; Dystonia; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary	1991
Modulatory role for CCK-B antagonists in Parkinson's disease. Clinical neuropharmacology, 1990, Volume: 13, Issue:4 Topics: Animals; Benzodiazepinones; Carbidopa; Cholecystokinin; Devazepide; Dopamine Agents; Levodopa; Male; Motor Activity; MPTP Poisoning; Oxazines; Parkinson Disease, Secondary; Phenylurea Compounds; Receptors, Cholecystokinin; Saimiri	1990
Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Antiparkinson Agents; Carbidopa; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Levodopa; Macaca mulatta; Neurologic Examination; Parkinson Disease, Secondary; Stereotyped Behavior	1991
Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. Journal of neural transmission. Parkinson's disease and dementia section, 1991, Volume: 3, Issue:1 Topics: Acetylcarnitine; Animals; Carbidopa; Caudate Nucleus; Electroretinography; Female; Homovanillic Acid; Immunohistochemistry; Levodopa; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Substantia Nigra	1991
The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography. Brain research, 1990, Oct-29, Volume: 531, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Carbidopa; Corpus Striatum; Deoxyglucose; Flunitrazepam; gamma-Aminobutyric Acid; Globus Pallidus; Levodopa; Macaca fascicularis; Neurons; Organ Specificity; Parkinson Disease; Parkinson Disease, Secondary; Tritium	1990
Antiparkinsonian activity of a single oral dose of PHNO. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:1 Topics: Administration, Oral; Adult; Aged; Carbidopa; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Oxazines; Parkinson Disease, Secondary; Reaction Time	1987
[A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Comptes rendus des seances de la Societe de biologie et de ses filiales, 1985, Volume: 179, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Carbidopa; Disease Models, Animal; Drug Combinations; Electromyography; Levodopa; Macaca mulatta; Movement Disorders; Parkinson Disease, Secondary; Pyridines	1985
Mood swings associated with the 'on-off' phenomenon in Parkinson's disease. Psychological medicine, 1987, Volume: 17, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Parkinson Disease, Secondary	1987
Parkinson's disease. Comprehensive therapy, 1986, Volume: 12, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Benserazide; Carbidopa; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Rats	1986
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life sciences, 1986, Jul-07, Volume: 39, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Brain; Brain Chemistry; Carbidopa; Carotid Artery, Internal; Disease Models, Animal; Dominance, Cerebral; Dopamine; Homovanillic Acid; Injections, Intra-Arterial; Levodopa; Macaca fascicularis; Movement; Neurons; Parkinson Disease, Secondary; Pyridines	1986
Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data. Electromyography and clinical neurophysiology, 1986, Volume: 26, Issue:8 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Electromyography; Levodopa; Macaca mulatta; Parkinson Disease, Secondary; Pyridines	1986
Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy. Movement disorders : official journal of the Movement Disorder Society, 1986, Volume: 1, Issue:4 Topics: Aged; Carbidopa; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levodopa; Male; Parkinson Disease, Secondary	1986
Parkinsonism induced by high-dose cytosine arabinoside. Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:3 Topics: Carbidopa; Cytarabine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Leukemia, Myelomonocytic, Acute; Levodopa; Middle Aged; Parkinson Disease, Secondary	1987